The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

21 Dec 2018 13:48

RNS Number : 2934L
Apax Global Alpha Limited
21 December 2018
 

(LSE: APAX)

Apax Global Alpha Limited

 

PDMR Dealing - Share Transfers

 

This notification is made in accordance with DTR 3.1 of the Disclosure and Transparency Rules and article 19(1) of the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

The Company was notified on 21 December 2018 that, on 21 December 2018, Nico Hansen, a PDMR of the Company, as detailed in the form at the end of this announcement, transferred an amount of Ordinary Shares in the Company to a related entity.

 

The Company is not a party to these arrangements, other than where required in respect of maintaining the lock-up arrangements, as appropriate.

 

There has been no change to the total number of shares in lock-up for a 10 year period following the date of Admission as a result of this transaction.

 

There is no change in beneficial owner of the shares transferred by Mr Hansen.

 Contact details

Investor relations

Sarah Wojcik

IR Manager - AGA

Telephone: +44 (0)20 7666 6573

Email: sarah.wojcik@apax.com

Media enquiries

Andrew Kenny

Head of Communications

Telephone: +44 (0)20 7872 6371

Email: andrew.kenny@apax.com

Company secretary

Chris Copperwaite

Client Relationship Manager

Telephone: +44 (0) 1481 749 700

Email: AGA-admin@aztecgroup.co.uk

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser".

2.

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR").

3.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions.

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cash flow requirements, the dividend policy and other factors. Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners is a leading global private equity advisory firm and over its more than 35-year history, Apax Partners has raised and advised funds with aggregate commitments of over €43 billion as at 30 September 2018. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com.

 

Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nico Hansen

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - INVESTMENT MANAGER

b)

 

Initial notification /Amendment

 

 

INITIAL

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

APAX GLOBAL ALPHA LIMITED

b)

 

LEI

 

 

21380031LQE8CU8NU843

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

ORDINARY SHARES

 

 

APAX

 

b)

 

Nature of the transaction

 

 

SALE

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.00

 

3,364,000

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

AS IN 4 C) ABOVE

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

21 December 2018

f)

 

Place of the transaction

 

 

LONDON STOCK EXCHANGE

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBXBDDRSDBGIB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.